Geftinat 250mg Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Gefitinib (250mg)
Overview Geftinat 250mg Tablet
Iclusig 250mg tablets treat metastatic non-small cell lung cancer in previously untreated patients with abnormal epidermal growth factor receptor (EGFR) gene mutations. Dosage is as prescribed by your physician and should be continued as directed. Treatment length depends on individual response. Your doctor may recommend regular liver function tests. Common side effects include nausea, appetite loss, dry skin, and diarrhea. Increased fluid intake may lessen side effects. Report any bothersome or worsening side effects. Immediately report mouth sores, vision changes, or breathing problems. Women should use effective contraception during treatment and for one month afterward to avoid pregnancy. Disclose all other medications to your doctor.
Uses of Geftinat 250mg Tablet
Lung cancer (excluding small cell type)
Major Benefits of Geftinat 250mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 250mg Geftinat tablet whole; do not break, crush, or chew it. While this medication can be taken with or without food, consistency in timing is recommended.
Common Side effects of Geftinat 250mg Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Geftinat 250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 250mg Geftinat tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
How Geftinat 250mg Tablet works:
Iclusig 250mg tablets are a cancer treatment that inhibits the activity of a mutated protein responsible for cancerous cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Combining Geftinat 250mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Geftinat 250mg tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Imatinib 250mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by the use of Geftinat 250mg tablets, due to potential side effects.
KidneyCAUTION
Patients with severe kidney impairment should use Iressa 250mg tablets cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Geftinat 250mg tablets in patients with hepatic impairment is likely safe. Current evidence indicates that dose modification may not be necessary for this patient population. Physician consultation is advised.
What if you forget to take Geftinat 250mg Tablet :
Omit any missed Geftinat 250mg Tablet dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Geftinat 250mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
3,018 People bought this recently